Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etravirine versus efavirenz neuropsychiatric safety trial in treatment-naive HIV-1 infection
2008-008655-42Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Human immunodeficiency virus infection type 1 comparing Etravirine arm with Efavirenz active control arm (2 arms). Started Feb 2009; status: completed.
02
Drugs
etravirineefavirenz
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-008655-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008655-42.